Vivanza Biosciences Limited

Equities

VIVANZA6

INE984E01035

Pharmaceuticals

Market Closed - Bombay S.E. 11:00:51 10/05/2024 BST 5-day change 1st Jan Change
6.55 INR -1.50% Intraday chart for Vivanza Biosciences Limited -14.38% -39.18%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Vivanza Biosciences Limited Announces Directors Resignation CI
Vivanza Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Vivanza Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Vivanza Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Vivanza Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Vivanza Biosciences Limited Announces Resignation of Manali S. Patel as Independent Director CI
Vivanza Biosciences Limited Announces Resignation of Girish Bhatt as Managing Director CI
Vivanza Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Vivanza Biosciences Bags Contract to Set Up Pharmaceutical Packaging Facility in Sudan MT
Vivanza Biosciences Limited Announces Receipt of Work Orders Worth Approximately USD 1 Million in Institutional and Industrial Categories CI
Vivanza Biosciences Shelves Planned Preferential Share Allotment MT
Vivanza Biosciences Limited cancelled the transaction announced on July 21, 2022 CI
Vivanza Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Vivanza Biosciences Limited announced a financing transaction CI
Vivanza Biosciences Limited Appoints Avinash G. Bhojwani as Company Secretary and Compliance Officer CI
Vivanza Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022 CI
Vivanza Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Vivanza Biosciences Limited Announces Change of Designation of Girish Bhatt to Non Executive Director CI
Vivanza Biosciences Limited Announces Appointment of Hemant Parikh as Chief Executive Officer CI
Vivanza Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Vivanza Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Vivanza Biosciences : Widens Net Loss in Fiscal Q4 MT
Vivanza Biosciences Limited Announces Resignation of Bhaskar Bhattacharya, Managing Director CI
Vivanza Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2021 CI
Vivanza Biosciences Limited Announces Board Changes CI
Chart Vivanza Biosciences Limited
More charts
Vivanza Biosciences Limited is an India-based specialty pharmaceutical company. The Company offers pharmaceutical products and pharma products. The Company is focused on commercializing generic pharmaceuticals, offering patients accessible medicines. The Company operates in only one that is trading of pharmaceutical product. Its products include gloves and surgical. Gloves products include latex examination gloves powdered, latex surgical powdered, latex free examination gloves-vinyl, latex free examination gloves-nitrile and Latex examination gloves-powdered. The Company’s products catalogues include Injectable Products, Vivanza Gloves and Therapeutic Index Injection. The Company offers gloves and surgical products to the industries include chemical, energy, industry, manufacturing and materials.
More about the company
  1. Stock Market
  2. Equities
  3. VIVANZA6 Stock
  4. News Vivanza Biosciences Limited
  5. Vivanza Biosciences Shelves Planned Preferential Share Allotment